Discovery of α-synuclein’s ‘fuzzy coat’ mechanism offers new insights into Parkinson’s

Parkinson’s disease (PD) and Lewy body dementia (LBD) are incurable and progressive neurodegenerative disorders, with some overlapping symptoms. An estimated 10 million people worldwide live with PD, while the figure for LBD—the second most common form of dementia after Alzheimer’s—is unclear. Both diseases involve Lewy bodies—abnormal clumps of α-synuclein protein in brain cells.

Most COVID-19 treatments found to be free of serious side effects in analysis of US studies

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an excessive immune response. Now, research from the Keck School of Medicine of USC has found that COVID-19 therapies cause few serious side effects, based on an evaluation of the full spectrum of evidence available from U.S. biomedical science.